Recent Finacing
Recent Raise
Cinclus Pharma develops potassium-competitive acid blocker small molecules including linaprazan/X842 for GERD and H. pylori eradication, conducting clinical trials and regulatory preparation for approval.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Cinclus Pharma.
